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Dystonia is characterized by excessive muscle contractions giving rise to 
abnormal posture and involuntary twisting movements. Although dystonia 
syndromes are a heterogeneous group of disorders, certain pathophysiological 
mechanisms have been consistently identified across different forms. These 
pathophysiologic mechanisms have been subsequently exploited for the 
development of non-invasive brain stimulation (NIBS) techniques able to 
modulate neural activity in one or more nodes of the putative network that is 
altered in dystonia and the therapeutic role of NIBS has been hence suggested. 
Here we review all studies that applied such techniques as a therapeutic 
intervention in any forms of dystonia, including the few works performed in 


















Dystonia is a syndrome characterized primarily by excessive muscle 
contractions giving rise to abnormal posture and involuntary twisting 
movements [1]. Dystonia can be classified in a number of ways, according to the 
age-at-onset, distribution, presence of additional signs, and etiology [1]. The 
current classification relies on two axes: The first defines the clinical features 
and phenomenology of dystonia in any given patient, whereas the second 
addresses etiological factors [1]. In most patients, however, definitive etiological 
conclusions cannot be reached and the dystonia syndrome is hence referred as to 
idiopathic. Despite dystonia being a widely heterogeneous group of disorders, 
certain pathophysiological mechanisms have been consistently identified across 
different dystonia forms [2,3], at least for those considered idiopathic.  
Three main abnormalities, which might be influencing each other, have been 
construed to represent the pathophysiological substrate of dystonia: loss of 
inhibition at different levels of the central nervous system, maladaptive 
(excessive) plasticity, and altered sensorimotor integration (for a review see [4]). 
These pathophysiological mechanisms might explain some clinical phenomena 
frequently observed in dystonia such as the motor overflow and the presence of 
sensory symptoms. Such abnormalities have been demonstrated to occur a 
various levels of the central nervous system (CNS) and dystonia is currently 
thought to be a network-disorder involving the sensorimotor cortices, the basal 
ganglia and, possibly, the cerebellum [5]. 
The current mainstream symptomatic therapy for dystonia is represented by 
chemodenervation by means of botulinum toxin (BoNT) injections [2]. 
However, while success rates in patients with cervical dystonia (CD) or 
blepharospasm (BPS) are reasonably high, in patients with focal hand dystonia 
(FHD) outcomes are more often disappointing, also due to frequent adverse 
effects. Moreover, BoNT might not be sufficient when dystonia is distributed 
over several body regions, as in many children with generalized dystonia. The 
role of deep brain stimulation (DBS) in dystonia is fairly accepted for some 
dystonic conditions (i.e., DYT1, DYT6, DYT11, tardive dystonia) and is 
emerging for others, but not all patients are suitable candidates [6]. Therefore, 
alternative therapeutic approaches are clearly needed.  
The putative pathophysiologic mechanisms of dystonia have been exploited for 
the development of non-invasive brain stimulation (NIBS) techniques. These 
would be able to induce plastic changes in one or more nodes of the altered 
network and possibly reverse the aforementioned abnormalities [7]. The concept 
of neuromodulation holds onto the hope of translating such NIBS techniques 
into novel therapeutic strategies for dystonia [7]. Two other review articles [8,9] 
have been previously produced about the therapeutic use of NIBS in dystonia, 
but both focused on patients with FHD only. Therefore, after providing basic 
principles of NIBS, we will here review all articles using NIBS techniques for 
therapeutic purposes in any form of dystonia, including the works performed in 
children. We will only focus on NIBS techniques (described in details in the 
next section), hence not covering the applications of DBS for dystonia. The 
interested readers are therefore referred elsewhere [6,10]. 
 
2. Principles of non-invasive brain stimulation 
Two main techniques are available for human NIBS: transcranial magnetic 
stimulation (TMS) and transcranial current stimulation (tCS). These 
neuromodulatory techniques are applied non-invasively over the scalp (figure 1) 
and hence avoid the possible complications associated with DBS surgery and the 
side effects of systemic medications [7-9,11,12]. Theoretically, both can be 
applied over selected cortical regions to modulate the specific cortical–
subcortical network that is supposedly linked with a given subset of symptoms. 
However, there is an established tendency of spread from the target brain area to 
neighboring areas, which might undermine the topographic selectivity of these 
techniques. Moreover, both rTMS and tDCS might be uncomfortable for 
patients and can further produce side effects, including the possibility of 
inducing seizures, which made some authors arguing that the term non-invasive 
would be inappropriate [13]. Perhaps, the term minimally invasive might be 
more appropriate. 
Beyond these two techniques, there is evidence that (peripheral) transcutaneous 
electrical nerve stimulation (TENS) can modulate motor cortex excitability [14] 
and will be therefore discussed here, despite not being classically considered a 
NIBS technique.  
 
2.1 rTMS 
Repetitive TMS (rTMS) refers to application of trains of repeated magnetic 
pulses delivered to the scalp.  Passing a brief current through an insulated coil 
held placed on the scalp surface generates a magnetic field perpendicular to the 
coil that, in turn, induces a weak current within the underlying cerebral cortex. 
Commonly used coils have a figure-8 shape able to stimulate brain cortical areas 
with a functional spatial resolution of 0.5 cm to 1 cm [15]. Using TMS, 
neuromodulatory effects can be elicited in a number of ways depending mostly 
on the frequency and/or pattern of stimulation: Low (<1 Hz) or high (> 5 Hz) 
frequency rTMS decreases or increases, respectively, cortical excitability. The 
exact mechanisms by which rTMS modulates the cortical excitability beyond the 
duration of the stimulation protocol are not clear. It is supposed that these are 
explained by long-term potentiation (LTP) and long-term depression (LTD) 
changes at synaptic level [16]. While these changes during the stimulation might 
be exerted by a direct influence on NMDA-dependent plasticity, late-LTP and 
late-LTD changes are arguably driven by gene expression regulation and protein 
synthesis [16].  
An alternative method of rTMS is theta burst stimulation (TBS), consisting of 
short, repeated bursts of TMS pulses at high frequency. In such case, the 
neuromodulatory effect relies on the pattern of stimulation with continuous TBS 
(cTBS) having inhibitory effects and intermittent TBS (iTBS) facilitatory  
effects. In actual fact, a single train of TBS induces a mixture of suppressive and 
facilitatory effects, with facilitation building up faster and suppression being 
more powerful in the long-term [17]. Since it is assumed that both mechanisms 
saturate at some level, the results might be explained upon the duration of the 
stimulation (i.e. as long as inhibition is builds up in the long run) [17]. 
Accordingly, a short, intermittent protocol as iTBS would favor rapid build-up 
of facilitation [17]. In contrast, a longer lasting continuous protocol such as 
cTBS would initially produce facilitation, but this would saturate and inhibitory 
effects (which build up slower but saturate at higher level) would eventually 
dominate [17]. This argument is however speculative and the exact mechanisms 
whereby TBS induces plastic changes are not entirely clear, the effects also 
depending on the intensity of stimulation [18-20].  
It should be noted, however, that there might be a significant amount of inter-
individual variability in response to such protocols. In fact, some subjects show 
facilitation after 1-Hz rTMS and others show excitability suppression after 10-
Hz rTMS [21]. Some authors suggested a role for genetic polymorphisms in the 
observed inter-individual variability [22].  
 
2.2 tCS  
Transcranial current stimulation refers to the application of an eletrical current 
through a pair of surface electrodes placed onto the scalp. tCS does not induce 
massive synchronized discharge of action potentials as with TMS techniques 
(e.g., does not induce activity in resting neuronal networks), but modulates 
spontaneous neuronal activity [23,24].  
Two main tCS techniques have been developed. In the most commonly used 
technique, the transcranial direct current stimulation (tDCS), a weak direct 
current delivered through the scalp is able to induce polarity-specific changes of 
resting membrane potential. That is, cortical excitability is diminished by 
cathodal stimulation which hyperpolarises neurons, while anodal stimulation 
causes an increase of excitability by depolarizing neurons [23, 25]. The 
magnitude of the after-effects of tDCS are proportional to the intensity and 
duration of the applied current. Differently from rTMS, for which the intensity 
used for any single subjects is based on the individual rest- or active-motor 
threshold, for tCS (both direct and alternating) there is no such a proxy and the 
intensity is set at either 1 or 2 mA. 
With the transcranial alternating current stimulation (tACS), both electrodes 
have equivalent effects that are dependent on the oscillating current frequency 
[24]. Accordingly, 1 mA tACS with frequency outside the conventional EEG 
range [e.g., with frequencies of 140 Hz and in the low kHz range (1–5 kHz)] 
increases excitability similarly to anodal tDCS [26,27]. When tACS is applied 
with frequency in the EEG range, it is supposed to entrain with or synchronize 
neuronal networks, and to induce changes in ongoing oscillatory brain activity. 
The efficacy of the stimulation seems to be also dependent on the power of 
intrinsic oscillations at baseline [28]. When applied over M1, 10-Hz or 15-Hz 
tACS leads to a pattern of inhibition of cortical excitability [29,30], while 20-Hz 
tACS increases cortical excitability [31].    
 
2.3 TENS 
The concept behind TENS stems from the evidence that manipulations of 
afferent input can induce lasting changes within the primary sensori-motor 
cortex [32-34]. The central effects of TENS are dependent on the frequency of 
the stimulation, with low frequency (1-4 Hz) increasing and high frequency (>50 
Hz) depressing sensori-motor excitability. The suggestion that plastic changes 
occur centrally is corroborated by the fact that peripheral (M-wave) and spinal 
(H-wave) excitability remain unchanged after TENS [14]. The exact 
mechanisms whereby TENS modulate sensory-motor excitability are not clear, 
with some authors speculating it could induce LTP changes at inhibitory 
synapses [14].     
 
 
3. Search strategy 
We searched the Medline database (via PubMed, a service of the National 
Library of Medicine’s National Center for Biotechnology Information; 
http://www.ncbi.nlm.nih.gov) for anytime publications using the following 
terms: Term A = [neuromodulation OR non-invasive brain stimulation OR 
repetitive transcranial magnetic stimulation OR theta burst stimulation OR 
transcranial current stimulation OR electrical stimulation OR rTMS OR tCS OR 
tDCS OR tACS OR TENS] AND term B = [dystonia]. All types of original 
articles, including case reports, were included if NIBS protocols were performed 
for therapeutic purposes or had at least one robust clinical outcome (i.e., we 
excluded pure pathophysiologic studies). Moreover, studies for which details 
about the stimulation protocol were not fully provided were excluded. Only 
articles written in English were included. Review articles were checked to 
include relevant articles not indexed in the electronic database.  
  
4. NIBS in children with dystonia 
Only three studies [35-37] from the same group evaluated the therapeutic 
potential of NIBS in children with dystonia, of which only one had a double-
blinded, sham-controlled design. All three used tDCS. A summary of the studies 
evaluating NIBS in children with dystonia is provided in table 1.  
In 2012 Young et al. performed an open-label study with cathodal tDCS in 10 
children with dystonia due to different etiologies (e.g., 2 patients had idiopathic 
dystonia, whereas in the remaining dystonia was secondary to a variety of 
causes, table 1) using a single-session cathodal stimulation over the motor cortex 
contralateral to the most affected side [35]. They failed to demonstrate any 
improvement on the Barry-Albright Dystonia (BAD) scale, but observed a non-
significant reduction of the motor overflow during an electromyogram tracking 
task [35]. Hence, they repeated the experiment on 14 children with dystonia 
using a double-blinded, sham-controlled design with cathodal tDCS [36]. 
Similarly to the above, there was no significant clinical change as measured by 
the BAD scale, but they found a significant reduction in the motor overflow, 
although the effect size was admittedly small [36]. Finally, Bhanpuri et al. 
attempted to explore whether repeated tDCS sessions could lead to a cumulative 
effects with meaningful clinical results in 9 patients, again with different 
etiologies accounting for their dystonia syndromes [37]. Using a double-blinded, 
sham-controlled design, they assessed over 5 sessions whether cathodal or 
anodal stimulation over the motor cortex contralateral to the most affected side 
could be beneficial. They failed to demonstrate any clinical and electromyogram 
changes [37]. However, as observed in prior studies, there was a great inter-
subject variability and individual analysis suggested that cathodal stimulation 
over the motor cortex could be in fact beneficial, whereas anodal tDCS even 
worsened motor performance in some patients. The major pitfall of all 3 studies 
is the inclusion of very heterogeneous patients (table 1), which hampers drawing 
definitive conclusions. Although the authors could not identify a clear pattern of 
response between “primary” and “secondary” patients, sample sizes were very 
small to allow such type of comparison. Therefore, larger, double-blinded and 
sham-controlled studies would be required in homogenous groups of patients. 
From a practical standpoint, it is to be acknowledged that in all 3 studies a small 
subset of patients did not tolerate the intensity of the stimulation (initially set 
between 1 and 2 mA), so that it was reduced below 1 mA and all patients but 
one could complete the protocol.  No major side effects were observed, largely 




5. NIBS in adults with dystonia 
5.1 Focal hand dystonia 
5.1.1 rTMS 
Eight studies were examined [39-46], of which only one had a double-blinded 
design. A summary of these studies is provided in table 2. There was a high 
heterogeneity in terms of design (open-label, single-blinded, with or without 
sham sessions and/or cross-over) and of patients included. The majority of 
studies included patients with writer’s cramp (WC) with the rationale of 
applying inhibitory protocols to the cortical motor areas contralateral to the 
affected side. Siebner et al. found that a single-session of 1 Hz rTMS over M1 
reduced writing pressure and this was somewhat mirrored by a normalization of 
the cortico-cortical inhibition and a prolongation of the cortical silent period 
(CSP) [39]. Similar results were obtained by Murase et al. in a single-blinded, 
sham-controlled study using 0.2 Hz rTMS over the premotor cortex (PMC), but 
not M1 or supplementary motor area (SMA) [41]. The therapeutic role of low-
frequency rTMS over PMC has been investigated in different studies. A pilot 
TMS-PET study on seven FHD patients employed a single session 1 Hz rTMS 
for 30 minutes over the dorsal PMC (dPMC) and evaluated perfusion before and 
after the magnetic stimulation. Although cerebral blood flow was decreased at a 
larger extent in lateral and medial premotor areas, putamen, and thalamus after 
inhibitory rTMS of dPMC in dystonic patients, neither handwriting nor global 
clinical score improved [40]. Conversely, Borich et al. showed a significant 
improvement of handwriting performance (lasting up to 10 days after the end of 
the stimulation period) by inhibiting the PMC with 5 consecutive 1 Hz rTMS 
sessions [42]. Importantly, such an improvement was not observed after a single 
session, suggesting cumulative effects with repeated sessions. In contrast to the 
above, Kimberley et al. failed to show any clinical improvement targeting the 
PMC with 5 consecutive sessions of 1Hz rTMS [45]. However, their 
experimental group was heterogeneous as it included 7 patients with WC and 5 
with musicians’ dystonia  (MD) [45]. The flaw of patient heterogeneity was 
somewhat investigated in another study from Kimberley et al. [46] which, 
despite yielding negative results, showed self-rated improvement with large 
effect sizes (suggesting clinical meaningfulness) in some subjects. The authors 
therefore advocated the need of identifying baseline predictors to distinguish 
responders from non-responders [46]. The therapeutic role of PMC in FHD has 
been further questioned by Huang et al. [44] who adopted a single-blinded, 
sham-controlled design with 5 consecutive sessions of cTBS over the PMC and 
failed to show any clinical changes, despite a significant increase in cortical 
inhibition. Finally, the study by Havrankova et al. was the only one adopting a 
double-blind design with cross-over [43]. The authors assessed whether 5 
consecutive sessions of 1 Hz rTMS over S1 could be beneficial in 11 patients 
with WC and they observed an improvement in both subjective and objective 
measures of handwriting lasting up to 2 weeks after the stimulation period, 
although no changes were observed for the BFMDS score [43]. 
 
5.1.2 tDCS 
Seven studies were included [47-53] (table 2), all of which but one had a 
double-blinded design [52]. In two consecutive studies, Buttkus et al. showed 
that single-sessions of both cathodal and anodal tDCS over M1 contralateral to 
the affected side are not effective in patients with MD [47,48]. Similar 
(negative) results were obtained in 12 patients with WC by Benninger et al. [49], 
who applied cathodal tDCS over M1 for three 20-minute sessions over one 
week. Conversely, Furuya et al. succeeded in showing a significant 
improvement in patients with MD targeting M1 bilaterally, but only when the 
stimulation was performed during motor (re)training and the cathode was placed 
over the affected hemisphere [50]. This would suggest that a combined use of 
bi-hemispheric tDCS with bimanual motor retraining is required to elicit 
improvement of rhythmic accuracy of a trained sequence of finger movements. 
Similar results were obtained by Rossett-Llobet et al. [52], who used repetitive 
sessions of bi-hemispheric tDCS over the sensorimotor cortices (e.g., 5 
consecutive sessions/week for two consecutive weeks) combined with sensori-
motor training. They showed that the combination of bi-hemispheric tDCS (with 
the cathode applied contralateral to the affected side) significantly increase the 
effectiveness of the rehabilitation programs. Finally, two studies assessed the 
potential therapeutic role of cerebellar tDCS [51,53] yielding somewhat 
contradictory results. Indeed, Bradmann argued for an improvement of 
handwriting kinematics following anodal tDCS of the ipsilateral cerebellum 
[53]. However, no clinical changes were observed using validated dystonia 
severity scales. Moreover, there was observed an unexpected decrease of 
cerebellar-brain inhibition (CBI), leaving the question open of what the 
mechanisms underlying the kinematic improvement are. Similarly, Sadnicka et 
al. did not show any clinical improvement or cortical excitability changes in 10 
patients with WC after anodal tDCS over the ipsilateral cerebellum [51]. Given 
that high heterogeneity in terms of cortical excitability responses was observed, 
the authors claimed that inter-subject variability might undermine cerebellar 
stimulation as a therapeutic strategy for FHD [51]. 
 
5.1.3 TENS 
TENS applied on forearm flexor muscles was used in a randomized, double-
blind, placebo-controlled crossover study in 10 WC patients [54]. The frequency 
of stimulation was of 50 Hz and intensity was below the pain threshold and 
muscular contraction. Electrical stimuli were administered throughout each 20-
minute session in 2-second trains (100 stimuli/train) separated by 2-second 
pauses. The authors found that 10 sessions in 2 weeks improved some objective 
and subjective aspects of writing, although no change was seen in a disability 
score [54]. The effect lasted for about 6 weeks [54]. In a subsequent study it was 
demonstrated that hand writing improvement after one TENS session on the 
forearm flexor muscles was paralleled by a significant reduction of MEP from 
the flexor muscles and an increase of the MEP from the extensor muscle in 10 
WC patients [55].   
 
5.2 Craniocervical dystonia 
5.2.1 rTMS/cTBS 
Three studies using either rTMS or cTB were performed in patients with 
cervical dystonia (CD) [56-58], whereas only one used rTMS in patients with 
blepharospasm [59]. An overview of these studies is provided in table 3. Koch 
and colleagues used repeated session of cTBS targeting the lateral cerebellum 
bilaterally in a double-blind, sham-controlled fashion over two weeks in a total 
of 18 CD patients [56]. They found a significant reduction of the at the end of 
the protocol for the real cTBS but not for sham stimulation [56]. However, the 
benefit was not maintained at 2- and 4-week follow-up [56]. In addition, they 
demonstrated a reduction of heterotopic paired associative stimulation excessive 
facilitation following cTBS, suggesting that modulation of CBI can indeed 
modify some of the pathophysiological substrates of dystonia and lead to a 
clinical improvement [56].  
Pirio Richardson et al. [57] performed a single-blinded, sham-controlled, low 
frequency rTMS study on a number of cortical areas to find out the best target to 
use in CD dystonia. Despite non-significant, the larger improvements on the 
TWSTRS were observed following rTMS over M1 and dPMC [57]. Zittel and 
colleagues applied a similar protocol of low frequency rTMS over S1/M1 and 
demonstrated that short-latency afferent inhibition (SAI) could be normalized 
although this did not reflect any changes in symptoms severity [58].  
Finally, Kranz et al. performed a double-blind, sham-controlled study on 12 BPS 
patients using a single session low frequency rTMS study [58]. The target was 
set on the Anterior Cingulate Cortex (ACC) in the point of maximal MEP for the 
orbicularis oculi muscle. They found that all clinical outcomes (both patient- and 
clinician-rated) improved along with a “normalization” of the blink reflex 
recovery cycle [59]. 
  
5.2.2 tCS 
Only two case-reports [60,61] have been published thus far, of which one with 
the use of tDCS and the other one with a mixed design using both tDCS and 
tACS. In 2011 Angelakis et al. showed that 15Hz tACS over C3/C4 (to target 
the supplemental motor cortex, SMC) was superior to cathodal tDCS over C4 
and led to a significant improvement of the clinical picture, with the TWSTRS 
reducing of about 50% [60]. In addition, the pain TWSTRS-subscale had a 
reduction of almost 75% [60]. It was also shown that the effects persisted one 
months after the stimulation protocol, suggesting that multiple tACS sessions 
have cumulative effects [60]. Bradman et al. instead used repeated sessions of 
anodal tDCS over the cerebellum, bilaterally, and right M1 (e.g. contralateral to 
the “most affected” side) [61]. They found a reduction of the TWSTRS of about 
40% (the pain TWSTRS-subscale decreased of about 55%) as well as of other 
dystonia-specific quality-of-life scales [61]. The clinical results were mirrored 
by electrophysiological changes in corticomotor excitability [61]. Importantly, 
the stimulation protocol was performed starting one week after botulinum toxin 




 Although only few data are available in dystonia yielding somewhat 
contradictory results (figure 2), the works reviewed here could pave the way for 
future studies on a larger scale. The aims of the current review were in fact to 
identify potential issues for the use of NIBS for the treatment of dystonia. As a 
result, four main questions are to be addressed.  
1) Is there any consensus regarding specific NIBS settings to be used? 
The results obtained by the studies reviewed here were often negative and this 
might undermine the theoretical hypothesis behind the use of these techniques as 
therapeutic tools. It might well be that the aimed inhibitory effect of NIBS (by 
means of low-frequency rTMS or anodal tDCS) could not outweigh excessive 
cortical excitability observed in dystonia, at least with single stimulation 
sessions. There is preliminary evidence in fact that cumulative effects can be 
obtained by repeated stimulation over consecutive days [37,43,60]. Hence, the 
results of single-session studies might have been negative simply because of an 
insufficient number of stimulation sessions [62]. However, it should be also 
noted that there is no consensus about the setting of these techniques and an 
incomplete knowledge of the physiological effects of NIBS. As to rTMS, the 
after-effects are dependent on the frequencies, phases (monophasic/biphasic) 
[63], intensity (sub-threshold or supra-threshold), on the total number of pulses 
[64]. Also, the stimulation might be more (or less) focused on the brain target 
according to the specific type of coil that is used and this might influence the 
final outcome [59,65]. Hence, studies comparing different stimulation settings 
might be worth as well as works aimed to compare different techniques (i.e. 
rTMS vs tCS). Finally and quite obviously, accurate positioning of the 
coil/electrodes on the brain target is critical [43] and different studies adopted 
different ways for the same target. A consensus in this regard would also 
enhance comparability across different studies.  
2) Is there clarity about the target to be stimulated? 
After the initial work by Siebner et al. showing an improvement in FHD after 
inhibition of M1 [39], Murase et al. provided evidence that PMC could be a 
better target and four subsequent studies used the PMC contralateral to the 
affected side as stimulation target [41]. Subsequent works yielded contradictory 
results with four studies failing to show significant benefits in objective 
measures, despite self-rated improvements were reported in some of these 
studies [40-46]. Interestingly, Borich et al. reported an improvement of 
handwriting performance, but this was only observed after 5 stimulation 
sessions [42]. This might imply that PMC could be in fact a promising target but 
repeated sessions of stimulation would be required for clinically meaningful 
effects, as proposed above. Finally, S1 has been proved as an efficacious 
alternative target with the improvement observed in both objective and 
subjective measures (again after 5 sessions of stimulation) [43]. With regards of 
tDCS, all studies [47-49,51,53] but two [50,52] failed to show any significant 
changes either by stimulating M1 or the cerebellum and regardless of the type of 
stimulation (e.g., chatodal or anodal). Interestingly, the two studies showing a 
potential benefit of tDCS applied a bi-hemispheric stimulation over the primary 
sensorimotor cortices with the cathode over the affected hemisphere and in both 
the stimulation was delivered during the execution of motor retraining [50,52]. It 
is not entirely clear whether it is the type of montage with bi-hemispheric 
stimulation or the combination of motor retraining and tDCS to be required to 
produce the improvement.  
The few studies performed in CD also yielded contradictory results. The study 
by Pirio Richardson [57], similarly to that of Murase in FHD [41], is the only 
one comparing different stimulation targets in a population of CD. They found 
that the largest improvement was observed for stimulation of the PMC and M1 
[57]. Preliminary positive results (with small size effects) have been 
demonstrated after cTBS of the cerebellum [56]. As far as tCS is concerned, the 
two case-report published so far [60,61] have shown promising results and it has 
been claimed that tACS could be superior to tDCS, but there are no studies 
indicating which should be the best target to stimulate. 
Although PMC has been proved as one of the most promising targets for both 
FHD and CD, it is unclear why this should be the case. PMC is a complex 
structure that has multiple connections with the SMA, the sensorimotor cortex, 
the anterior cingulate and the basal ganglia and Tyvaert and colleagues have 
demonstrated that sensorimotor integration (one of the main pathophysiological 
abnormalities in dystonia) could be ameliorated by low-frequency rTMS of the 
PMC [65]. The reasons why stimulating any other nodes of the sensori-motor 
network has not always produced similar results remain to be determined and 
further physiological studies are warranted to fully understand the “network 
effect” of NIBS [13]. Interestingly, there is preliminary evidence that peripheral 
electrical stimulation would modulate sensorimotor integration and lead to an 
improvement of dystonia [54,55]. Modulating sensory afferents by means of a 
protocol that employs the physiological sensory pathway might prove an 
approach with higher topographic selectivity, as the stimulation can in fact be 
delivered on the affected body part.   
3) Are NIBS suitable only for some dystonia populations? 
As far as children with dystonia are concerned, despite overall negative results, 
there are some indications that cathodal tDCS over primary sensorimotor 
cortices can be to some extent beneficial in reducing motor overflow [35-37]. 
However, it should be noted that: 1) there is a paucity of studies in children with 
a total population of 33 subjects studied thus far; and 2) there was an impressive 
heterogeneity in terms of etiology. All three studies performed in children [35-
37] in fact enrolled subjects with non-progressive CP, secondary (progressive) 
dystonia and genetic forms such as DYT1, rendering the results hardly 
interpretable. Moreover, it should be noted that in these studies some children 
did not tolerate the stimulation at full intensity, so that it was reduced and this, 
as mentioned above, might have also affected the results. This is a potential 
issue that needs to be considered when evaluating NIBS in children. As for now, 
there is no robust evidence to consider NIBS for dystonia in children. 
As to adults with dystonia, the majority of studies were focused on patients with 
FHD [39-53]. This is due to the fact that patients with FHD usually respond less 
to BoNT injections than those with other types of focal dystonia, highlighting 
the need for novel therapeutic strategies. Moreover, FHD represents an 
interesting model to explore NIBS given that symptoms are generally confined 
to one body side. Despite this, there is no clear rationale to argue that only 
specific dystonia populations would benefit from NIBS, given that the main 
pathophysiological mechanisms underlying the manifestation of dystonia are 
shared across different sub-groups [3,4]. However, opposite results have been 
sometimes demonstrated for different forms of dystonia. For example, low 
frequency rTMS over S1 has been shown to enhance SAI in CD [58] and to 
reduce it in WC [66]. Hence, larger studies with homogenous populations are 
required to estimate the magnitude of benefit in each of these dystonia groups. 
4) Are available clinical scales sensitive enough to detect minimal changes? 
The final question is whether available clinical scales are in fact sensitive 
enough to detect minimal significant changes. Quite obviously, different scales 
were adopted across different studies and this hampers comparisons among 
them. One strategy to overcome such a hurdle might be considering as primary 
outcome in pragmatic RTCs patients’ willing to continue the treatment, while 
waiting for more sensitive clinical scale to be developed [67].  On the other 
hand, clinical assessments should be paralleled by neurophysiological 
evaluations in order to fully understand the neural circuits that NIBS modulate 




In summary, there remain many pitfalls regarding NIBS techniques as 
therapeutic tools for dystonia and at the current time none can be recommended. 
Moreover, there is lack of studies assessing whether NIBS can augment the 
effectiveness of rehabilitation or pharmacological treatments [68]. It is in fact  
interesting to note that some authors suggested the potential of NIBS to augment 
the benefit produced by BoNT injections [61], so that NIBS technique could be 
seen as complementary rather than alternative treatments. At the current stage, 
NIBS cannot be recommended for use in dystonia populations. However, further 
studies, possibly exploring novel techniques [69,70], are warranted to see 





Table 1. Summary of the studies using NIBS techniques in children with 
dystonia 
CP: Cerebral palsy; TBI: Traumatic brain injury; BAD: Barry-Albright 
Dystonia Scale; SMA: Supplementary motor area. 
Table 2. Summary of the studies using NIBS techniques in focal hand 
dystonia 
WC: writer’s cramp; HC: Healthy controls; FHD: Focal hand dystonia; MD: 
musicians’ dystonia; RMT: Rest motor threshold; AMT: Active motor threshold; 
PMC: premotor cortex; SMA: Supplementary motor area; dPMC: dorsal 
premotor cortex; SMC: sensorimotor cortices; BMFDS: Burke-Marsden-Fahn 
Dystonia Scale; WCRS: Writer’s cramp rating scale; ADDS: Fahn’s Arm 
Dystonia Disability Scale; CSP: Cortical silent period; BOLD: Blood-oxygen-
level dependent; CBI: Cerebellar-brain inhibition. 
Table 3. Summary of the studies using NIBS techniques in craniocervical 
dystonia 
CD: Cervical dystonia: BPS: Blepharospasm; HC: Healthy controls; RMT: Rest 
motor threshold; ACC: anterior cingulate cortex; PMC: premotor cortex; SMA: 
Supplementary motor area; dPMC: dorsal premotor cortex; MEP: Motor 
evoked potential; TWSTRS: Toronto Western Spasmodic Torticollis Rating 
Scale; CDQ-24: Craniocervical Dystonia Questionnaire; CDIP-58: Cervical 
Dystonia Impact Profile; BMFDS: Burke-Marsden-Fahn Dystonia Scale; PAS: 
Paired associative stimulation; CBI: Cerebellar-brain inhibition; BRR: Blink 
reflex recovery cycle.  
 
Figure 1. Summary of NIBS techniques for excitation and inhibition  
 
Figure 2. Graphical summary of the studies using rTMS or tCS 
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